Status:

UNKNOWN

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Lead Sponsor:

Eastern Hepatobiliary Surgery Hospital

Conditions:

Hepatocellular Carcinoma

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The aim of this study is to analyze the therapeutic effect of postoperative adjuvant chemotherapy with FOLFOX4 after hepatocarcinoma resection based on folate receptor-positive circulating tumor cells...

Detailed Description

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death globally. Hepatectomy remains the most widely practiced radical treatment for HCC despite having a high associated recurrence ...

Eligibility Criteria

Inclusion

  • Patients with HCC who received curative liver resection (R0);
  • Karnofsky Performance Score performance over 60;
  • The functions of the kidney, heart and lung and the blood system are normal and fittable for Licardin therapy;
  • The liver function is of grade A or B in Child-Pugh classification;
  • Patients agreed to collect peripheral blood for detection of CTC at the designated time point;
  • Patients should sign the informed consent of this study.

Exclusion

  • If postoperative liver function is Child C, it cannot tolerate chemotherapy;
  • Blood transfusion history within 1 month before enrollment;
  • Severe gastroesophagealvarices with red sign or with variceal hemorrhage before;
  • Malignant or metastatic tumor in other sites in last 5 years;
  • Patients can not be followed-up regularly;
  • Patients participating in other trials or received other treatment previously.

Key Trial Info

Start Date :

December 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

184 Patients enrolled

Trial Details

Trial ID

NCT04521491

Start Date

December 1 2020

End Date

December 31 2023

Last Update

August 20 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Eastern hepatobilliary surgery hospital

Shanghai, Shanghai Municipality, China, 200438